Fatigue and PARP Inhibitors
- PARP inhibitors, a class of drugs that can benefit almost all women with ovarian cancer, are commonly known to cause a feeling of decreased energy.
- While there is no one medication or treatment that can mitigate fatigue, light exercise can often help.
- The importance of maintaining a positive attitude shouldn’t be discounted, either.
However, the American Society of Clinical Oncology (ASCO) guidelines recommend PARP inhibitors be offered to women, with or without genetic mutations, who are newly diagnosed with stage III or IV ovarian cancer and have improved with chemotherapy.
Read More“We try to discuss with a patient that they should just bear with it for a while and see if it will just go away,” Dr. White says, explaining that, unfortunately, there is no one medication that will eliminate a woman’s fatigue.
Some doctors recommend light exercise for women who feel up to it, since activity has been known to help with fatigue.
“I think attitude really makes a big difference as far as the cancer patient is concerned,” Dr. White adds. “And I would encourage them to really have a positive attitude and know that we would continue to keep up with a modern treatment and they were getting the best treatment that we could get.”
Learn more about SurvivorNet's rigorous medical review process.